{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:50:43Z","timestamp":1791827443576,"version":"4.3.4"},"reference-count":39,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,9,22]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/bmjopen-2026-123684","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:25:44Z","timestamp":1791825944000},"page":"e123684","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Quality of antibiotics purchased on Bioko Island and four mainland districts of Equatorial Guinea: a cross-sectional medicine-quality survey"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4959-0577","authenticated-orcid":false,"given":"Harparkash","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Paris","sequence":"additional","affiliation":[{"name":"Health Protection Surveillance Centre (HPSC), Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerem\u00edas Nzamio","family":"Mba Eyono","sequence":"additional","affiliation":[{"name":"MCD Global Health, Malabo, Equatorial Guinea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Restituto Mba","family":"Nguema Avue","sequence":"additional","affiliation":[{"name":"MCD Global Health, Malabo, Equatorial Guinea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonder P","family":"Phiri","sequence":"additional","affiliation":[{"name":"MCD Global Health, Malabo, Equatorial Guinea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M","family":"Smith","sequence":"additional","affiliation":[{"name":"MCD Global Health, Hallowell, ME, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-9528","authenticated-orcid":false,"given":"Carlos A","family":"Guerra","sequence":"additional","affiliation":[{"name":"MCD Global Health, Hallowell, ME, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Riloha Rivas","sequence":"additional","affiliation":[{"name":"Ministry of Health and Health Infrastructures, Malabo, Equatorial Guinea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo A","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"MCD Global Health, Hallowell, ME, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"2026101210253189000_16.10.e123684.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5493","article-title":"Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis","volume":"349","author":"Currie","year":"2014","journal-title":"BMJ"},{"key":"2026101210253189000_16.10.e123684.2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks395"},{"key":"2026101210253189000_16.10.e123684.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.04.031"},{"key":"2026101210253189000_16.10.e123684.4","unstructured":"Grand View Research . Antibiotics market size, share and trends analysis report, 2025-2033. San Francisco (CA): Grand View Research; 2025. Available: https:\/\/www.grandviewresearch.com\/industry-analysis\/antibiotic-market [Accessed 4 Apr 2026]."},{"key":"2026101210253189000_16.10.e123684.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004638","article-title":"Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016-2019","volume":"22","author":"Osena","year":"2025","journal-title":"PLoS Med"},{"key":"2026101210253189000_16.10.e123684.6","unstructured":"World Bank . Drug-resistant infections: a threat to our economic future. World Bank: Washington (DC); 2017. Available: https:\/\/www.worldbank.org\/en\/topic\/health\/publication\/drug-resistant-infections-a-threat-to-our-economic-future [Accessed 25 Nov 2025]."},{"key":"2026101210253189000_16.10.e123684.7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-008587","article-title":"Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?","volume":"7","author":"Zabala","year":"2022","journal-title":"BMJ Glob Health"},{"key":"2026101210253189000_16.10.e123684.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041418","article-title":"Protocol for an interdisciplinary cross-sectional study investigating the social, biological and community-level drivers of antimicrobial resistance (AMR): Holistic Approach to Unravel Antibacterial Resistance in East Africa (HATUA)","volume":"11","author":"Asiimwe","year":"2021","journal-title":"BMJ Open"},{"key":"2026101210253189000_16.10.e123684.9","unstructured":"Pisani E . Antimicrobial resistance: what does medicine quality have to do with it? 2015. Available: https:\/\/amr-review.org\/sites\/default\/files\/ElizabethPisani MedicinesQualitypaper.pdf"},{"key":"2026101210253189000_16.10.e123684.10","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.22-0221"},{"key":"2026101210253189000_16.10.e123684.11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.23-0045","article-title":"Detection of Substandard and Falsified Antibiotics Sold in the Democratic Republic of the Congo Using Validated HPLC and UV-Visible Spectrophotometric Methods","volume":"109","author":"Tshilumba","year":"2023","journal-title":"Am J Trop Med Hyg"},{"key":"2026101210253189000_16.10.e123684.12","doi-asserted-by":"crossref","DOI":"10.1080\/20523211.2024.2375267","article-title":"Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review","volume":"17","author":"Asrade Mekonnen","year":"2024","journal-title":"J Pharm Policy Pract"},{"key":"2026101210253189000_16.10.e123684.13","unstructured":"World Health Organization . 1 in 10 medical products in developing countries is substandard or falsified. WHO: Geneva; 2017. Available: https:\/\/www.who.int\/news\/item\/28-11-2017-1-in-10-medical-products-in-developing-countries-is-substandard-or-falsified [Accessed 25 Nov 2025]."},{"key":"2026101210253189000_16.10.e123684.14","unstructured":"World Health Organization . Substandard and falsified medical products [fact sheet]. WHO: Geneva; 2018. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/substandard-and-falsified-medical-products [Accessed 22 Aug 2022]."},{"key":"2026101210253189000_16.10.e123684.15","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12298"},{"key":"2026101210253189000_16.10.e123684.16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1662","article-title":"Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis","volume":"1","author":"Ozawa","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2026101210253189000_16.10.e123684.17","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.14-0539"},{"key":"2026101210253189000_16.10.e123684.18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/14787210.2025.2477198","article-title":"Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications","volume":"24","author":"Saleem","year":"2026","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026101210253189000_16.10.e123684.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-018597","article-title":"Assessing the quality of antimalarial drugs in Equatorial Guinea: a follow-up study","volume":"10","author":"Kaur","year":"2025","journal-title":"BMJ Glob Health"},{"key":"2026101210253189000_16.10.e123684.20","unstructured":"WHO Expert Committee on Specifications for Pharmaceutical Preparations . Guidelines on the conduct of surveys of the quality of medicines. WHO technical report series no.966. 2016. Available: https:\/\/www.who.int\/publications\/m\/item\/ Annex-7-trs-no-966"},{"key":"2026101210253189000_16.10.e123684.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000052","article-title":"Guidelines for field surveys of the quality of medicines: a proposal","volume":"6","author":"Newton","year":"2009","journal-title":"PLoS Med"},{"key":"2026101210253189000_16.10.e123684.22","doi-asserted-by":"crossref","DOI":"10.1186\/s40545-020-00211-9","article-title":"A simplified checklist for the visual inspection of finished pharmaceutical products: a way to empower frontline health workers in the fight against poor-quality medicines","volume":"13","author":"Schiavetti","year":"2020","journal-title":"J Pharm Policy Pract"},{"key":"2026101210253189000_16.10.e123684.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2007.12.032"},{"key":"2026101210253189000_16.10.e123684.24","first-page":"239","article-title":"High Performance Liquid Chromatography (HPLC) Method Development and Validation Indicating Assay for Ciprofloxacin Hydrochloride","volume":"8","author":"Ali","year":"2011","journal-title":"J App Pharm Sci"},{"key":"2026101210253189000_16.10.e123684.25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4212\/cjhp.v63i4.934","article-title":"Stability of trisodium citrate and gentamicin solution for catheter locks after storage in plastic syringes at room temperature","volume":"63","author":"Cote","year":"2010","journal-title":"Can J Hosp Pharm"},{"key":"2026101210253189000_16.10.e123684.26","unstructured":"United States Pharmacopeia . USP-NF. Rockville (MD): USP. Available: https:\/\/online.uspnf.com\/uspnf [Accessed 4 Apr 2019]."},{"key":"2026101210253189000_16.10.e123684.27","unstructured":"The Fleming Fund . Gaps in AMR surveillance data across Africa to shape health policy reform. The Fleming Fund: London; 2023. Available: https:\/\/www.flemingfund.org\/publications\/gaps-in-amr-surveillance-data-across-africa-to-shape-health-policy-reform [Accessed 5 Apr 2026]."},{"key":"2026101210253189000_16.10.e123684.28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-67430-z","article-title":"The urgent need for African research collaboration on medicine quality","volume":"17","author":"Zeng","year":"2026","journal-title":"Nat Commun"},{"key":"2026101210253189000_16.10.e123684.29","unstructured":"Ministerio de Sanidad y Bienestar Social, Rep\u00fablica de Guinea Ecuatorial . LIMEGE: Lista de Medicamentos Esenciales de Guinea Ecuatorial. 4th edn.2012. Available: https:\/\/cdn.who.int\/media\/docs\/default-source\/essential-medicines\/national-essential-medicines-lists-(neml)\/afro_neml\/equatorial-guinea_neml_2012.pdf?sfvrsn=1f4e0936_1&download=true"},{"key":"2026101210253189000_16.10.e123684.30","unstructured":"The selection and use of essential medicines. WHO model list of essential medicines, 24th list. 2025. Available: https:\/\/www.who.int\/publications\/i\/item\/B09474 [Accessed 25 Aug 2025]."},{"key":"2026101210253189000_16.10.e123684.31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125577","article-title":"Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria","volume":"10","author":"Kaur","year":"2015","journal-title":"PLoS ONE"},{"key":"2026101210253189000_16.10.e123684.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000409","article-title":"Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea","volume":"2","author":"Kaur","year":"2017","journal-title":"BMJ Glob Health"},{"key":"2026101210253189000_16.10.e123684.33","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3201\/eid1511.090886","article-title":"Epidemic of Plasmodium falciparum malaria involving substandard antimalarial drugs","volume":"15","author":"Leslie","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"2026101210253189000_16.10.e123684.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2008.03.002"},{"key":"2026101210253189000_16.10.e123684.35","doi-asserted-by":"crossref","first-page":"7091278","DOI":"10.1155\/2020\/7091278","article-title":"Quality and Brands of Amoxicillin Formulations in Nairobi, Kenya","volume":"2020","author":"Koech","year":"2020","journal-title":"Biomed Res Int"},{"key":"2026101210253189000_16.10.e123684.36","unstructured":"World Health Organization . Substandard and falsified medical products. WHO: Geneva. Available: https:\/\/www.who.int\/medicines\/regulation\/ssffc\/ [Accessed 25 Aug 2022]."},{"key":"2026101210253189000_16.10.e123684.37","unstructured":"World Health Organization . Medical product alert no.11\/2019: falsified amoxicillin + clavulanic acid. WHO: Geneva; 2019. Available: https:\/\/www.who.int\/news\/item\/16-10-2019-medical-product-alert-n-11-2019-(english-version) [Accessed 25 Aug 2022]."},{"key":"2026101210253189000_16.10.e123684.38","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics13100943","article-title":"Perspectives on the Regional Strategy for Implementation of National Action Plans on Antimicrobial Resistance in the WHO African Region","volume":"13","author":"Yahaya","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"2026101210253189000_16.10.e123684.39","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4269\/ajtmh.23-0536","article-title":"Quality Assessment of Selected Essential Antimicrobial Drugs from Drug Retail Outlets of Selected Cities in Eastern Ethiopia","volume":"110","author":"Anjulo","year":"2024","journal-title":"Am J Trop Med Hyg"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-123684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:25:49Z","timestamp":1791825949000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-123684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,12]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/bmjopen-2026-123684"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-123684","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}